top of page
EN
EN
ZH
TRANSACTIONS & NEWS
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
January 23, 2023 at 1:11:25 PM
Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore
December 27, 2022 at 1:44:59 PM
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
December 22, 2022 at 1:22:57 PM
Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited
December 12, 2022 at 5:08:14 AM
China Pharma Holdings Acquires Dry Eye Disease Therapeutic Device Project
December 8, 2022 at 2:09:12 PM
Baozun Acquires Gap Greater China and Establishes Brand Management as a New Business Line
November 10, 2022 at 8:27:49 AM
bottom of page